0001399529-21-000120.txt : 20210617 0001399529-21-000120.hdr.sgml : 20210617 20210617211854 ACCESSION NUMBER: 0001399529-21-000120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paglia Regina M. CENTRAL INDEX KEY: 0001813985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 211026891 MAIL ADDRESS: STREET 1: C/O DICERNA PHARMACEUTICALS, INC. STREET 2: 33 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205993609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 wf-form4_162397911311628.xml FORM 4 X0306 4 2021-06-15 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001813985 Paglia Regina M. C/O DICERNA PHARMACEUTICALS, INC. 75 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Human Resources Officer Common Stock 2021-06-15 4 M 0 381 A 381 D Common Stock 2021-06-15 4 F 0 112 35.74 D 269 D Common Stock 2021-06-16 4 M 0 20000 12.93 A 20269 D Common Stock 2021-06-16 4 M 0 10000 22.58 A 30269 D Common Stock 2021-06-16 4 M 0 1564 26.62 A 31833 D Common Stock 2021-06-16 4 S 0 31464 35.6284 D 369 D Common Stock 2021-06-16 4 S 0 100 36.15 D 269 D Restricted Stock Units 2021-06-15 4 M 0 381 0 D Common Stock 381.0 1144 D Employee Stock Option (Right to Buy) 12.93 2021-06-16 4 M 0 20000 0 D 2029-02-28 Common Stock 20000.0 103414 D Employee Stock Option (Right to Buy) 22.58 2021-06-16 4 M 0 10000 0 D 2030-01-07 Common Stock 10000.0 52500 D Employee Stock Option (Right to Buy) 26.62 2021-06-16 4 M 0 1564 0 D 2030-06-30 Common Stock 1564.0 5261 D Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock. Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. The Reporting Person sold an aggregate of 31,564 shares of Common Stock on June 16, 2021 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 11.35% of 278,052 shares of Common Stock, which is the number of shares of Common Stock owned by the Reporting Person prior to the Shares Sold transaction reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the Reporting Person as of the date of this report. Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of June 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer on each applicable vesting date. The option vested 25% on the first year anniversary of the vesting start date of February 19, 2019 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the Reporting Person's continued service with the Issuer through each applicable vesting date. The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued service with the Issuer through each applicable vesting date. The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of July 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued service with the Issuer through the applicable vesting date. /s/ Douglas W. Pagan, attorney-in-fact 2021-06-17